Crossmark

A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report

Crossref DOI link: https://doi.org/10.1186/s12920-023-01602-y

Published Online: 2023-07-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qiao, Fei

Ren, Feng

Lu, Weiting

Yang, Haoran

Mo, Guiling

Wang, Shuangshuang

Liu, Lina http://orcid.org/0000-0002-5813-1375
Xu, Xiangtao
License Information

Text and Data Mining valid from 2023-07-25

Version of Record valid from 2023-07-25
More Information

Article History

Received: 19 September 2022

Accepted: 4 July 2023

First Online: 25 July 2023

Declarations

:

: The study protocol was approved by the Ethics Committee of Affiliated Hospital of Nanjing University of Traditional Chinese Medicine. All the experiments were performed in accordance with relevant guidelines and regulations. The informed consent was obtained from the patient, her parents and the ‘control’ participant.

: Written informed consent was obtained from the patient, her parents and and the ‘control’ participant for publication of this case report and any accompanying images, other personal or clinical details. A copy of the written consent is available for review by the Editor of this journal.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below